Page number | Chapter | |
Situation and business activities of the Company and the Groupe | 22 to 35 | 1.1; 1.2; 1.3 |
Business results of the Company and the Groupe | 200 to 202; 276 to 278; 296 to 297; 298 | 6.1 to 6.3; 7.1; 7.2; 7.4 (Note 27); 7.5 |
Objective and exhaustive analysis of business developments, results and financial position of the Company and the Groupe | 35 to 37;186 to 196 | 1.4; 5.1 to 5.5 |
Key performance indicators of a financial and, as the case may be, non-financial nature relating to the Company’s specific activity, including information on environmental and employee matters | 136 to 184; 188 to 193 | 4; 5.2; 5.3; 5.4 |
Key events occurring between the reporting date of the financial year and the date the report is prepared | 40; 71; 72 | 2.1; 3.1.1.2; 3.1.1.3 |
Foreseeable development of the Company and the Groupe | 37; 197 | 1.4.3; 5.7 |
Dividends distributed over the three preceding years and amount of income distributed during the same years eligible for 40% deduction | 196 | 5.6 |
Investments or controlling interests in companies headquartered in French territory | 27; 35 to 37 | 1.2.2; 1.4.1 |
Page number | Chapter | |
Description of the main risk factors and uncertainties faced by the Company and Groupe | 40 to 44 | 2.1 |
Indications of financial risks linked to the effects of climate change and presentation of measures taken to reduce them through implementation of a low carbon strategy | 169; 173 to 177; 179 | 4.4.2.6; 4.5; 4.6 |
Main features of internal control and risk management procedures relating to the preparation and processing of the accounting and financial information | 45 to 47 | 2.2 |
Indications of objectives and policy regarding each main category using hedge accounting, and the exposure to risks relating to prices, credit, liquidity and cash flow (use of financial instruments by the Company) | 44; 191 to 193; | 2.1; 5.4; 6.6 (Notes 1.3, 23, 28, 29) |
Declaration of non-financial performance | 136 to 184 | 4 |
Duty of Care plan to identify risks and prevent serious infringements in the areas of human rights, fundamental freedoms, health, security and the environment, resulting from the activity of the Company and of the companies it controls and from the activities of sub-contractors and suppliers | 166 to 169 | 4.4.2 |
Research and development activities | 38; 209 | 1.6; 6.6 (Note 1.3) |
Existing branches | N/A |
